Covid-19 man­u­fac­tur­ing roundup: Pro­duc­tion ramp-ups ap­proved by EU; mR­NA boom spurs Lon­za­'s Chi­nese ex­pan­sion

The Eu­ro­pean Union’s hu­man med­i­cines com­mit­tee ap­proved a ramp-up in man­u­fac­tur­ing ca­pac­i­ty for Mod­er­na and Pfiz­er/BioN­Tech’s mR­NA vac­cines Tues­day.

A site in Saint-Rémy-sur-Avre, France, will pro­vide fill-fin­ish ser­vices for the vac­cine Comir­naty af­ter it was ap­proved by the FDA on Mon­day.

Mod­er­na’s vac­cine will get a fill-fin­ish boost at Catal­ent’s Bloom­ing­ton, IN site. That’s in ad­di­tion to the scale-up ap­proved at Mod­er­na’s Nor­wood, MA site, in ad­di­tion to Lon­za’s Portsmouth, NH fa­cil­i­ty. The sites are set to pro­vide 40 mil­lion more dos­es to the EU in Q3 of this year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER